Redenlab
Adam Vogel has a diverse work experience in various research and academic roles related to speech pathology and genetic diseases. Adam served as the Director & Professor at the Centre for Neuroscience of Speech at The University of Melbourne since 2010. In 2016, they became the Chief Executive Officer of Redenlab. Adam also worked as a Research Associate at the Murdoch Childrens Research Institute, where they focused on genetic diseases affecting the nervous system. Adam served as a Consultant Speech Pathologist at Wesley Medical Research and Monash Health, as well as a Consultant Speech Pathologist at Eastern Cognitive Disorders Clinic. Adam also worked as a Director at Melbourne Speech Pathology. Furthermore, they held positions as an Adjunct Professor at Monash University and an Honorary Clinical Research Fellow at Bionics Institute. Adam's career also includes a role as a Research Fellow at the Institute for Safety, Compensation & Recovery Research.
Adam Vogel completed their high school education at St Peters Lutheran College from 1993 to 1997. Adam then pursued a Bachelor of Arts degree in Psychology at The University of Queensland from 1998 to 2000. Following this, they earned a Master's degree in Speech Pathology from The University of Queensland from 2000 to 2003. Subsequently, they obtained a PhD in Neuroscience from the University of Melbourne, where they studied from 2007 to 2010.
This person is not in any teams
Redenlab
Redenlab Inc is an industry leading neuroscience focussed tech bio. We use speech and language biometrics to improve decision-making in clinical trials. Whether the trials take place in clinic, at home, or virtually, our tests are sensitive and reliable, accurately detecting subtle changes caused by disease or treatment. Our speech software and hardware solutions meet all the regulatory requirements for data security and integrity in clinical trials, including 21 CFR Part 11 and HIPAA. Follow us to find out more about our groundbreaking projects and explore the future of speech analysis at www.redenlab.com.